{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-10",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20140430",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 5",
          "submission_class_code_description": "Type 5 - New Formulation or New Manufacturer",
          "application_docs": [
            {
              "id": "44917",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205382Orig1s000SumR.pdf",
              "date": "20150811",
              "type": "Summary Review"
            },
            {
              "id": "10440",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/205382Orig1s000ltr.pdf",
              "date": "20140501",
              "type": "Letter"
            },
            {
              "id": "19637",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205382s000lbl.pdf",
              "date": "20140502",
              "type": "Label"
            },
            {
              "id": "22984",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205382Orig1s000TOC.html",
              "date": "20150811",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "8",
          "submission_status": "AP",
          "submission_status_date": "20171020",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "50131",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/205382Orig1s008ltr.pdf",
              "date": "20171023",
              "type": "Letter"
            },
            {
              "id": "50167",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205382s008lbl.pdf",
              "date": "20171024",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "10",
          "submission_status": "AP",
          "submission_status_date": "20190606",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "58994",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/205382Orig1s010ltr.pdf",
              "date": "20190607",
              "type": "Letter"
            },
            {
              "id": "58997",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205382s010lbl.pdf",
              "date": "20190607",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "6",
          "submission_status": "AP",
          "submission_status_date": "20170613",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "48714",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205382s006lbl.pdf",
              "date": "20170614",
              "type": "Label"
            },
            {
              "id": "48751",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/205382Orig1s006ltr.pdf",
              "date": "20170616",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20160224",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "19638",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205382s002lbl.pdf",
              "date": "20160226",
              "type": "Label"
            },
            {
              "id": "32664",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/205382Orig1s002ltr.pdf",
              "date": "20160226",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "13",
          "submission_status": "AP",
          "submission_status_date": "20231213",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "76796",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/205382Orig1s013ltr.pdf",
              "date": "20231214",
              "type": "Letter"
            },
            {
              "id": "76823",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205382s013lbl.pdf",
              "date": "20231214",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "NDA205382",
      "sponsor_name": "GLAXO GRP ENGLAND",
      "openfda": {
        "application_number": [
          "NDA205382"
        ],
        "brand_name": [
          "INCRUSE ELLIPTA",
          "UMECLIDINIUM ELLIPTA"
        ],
        "generic_name": [
          "UMECLIDINIUM"
        ],
        "manufacturer_name": [
          "GlaxoSmithKline LLC",
          "Prasco Laboratories"
        ],
        "product_ndc": [
          "0173-0873",
          "66993-189"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "UMECLIDINIUM BROMIDE"
        ],
        "rxcui": [
          "1539251",
          "1539885",
          "1596444",
          "1596445"
        ],
        "spl_id": [
          "4049ca45-7739-4d4a-bcce-50c5b3c7415f",
          "78029af6-3c01-4be0-8439-ec3c22b4abb7"
        ],
        "spl_set_id": [
          "dbb64747-1505-49d7-9a33-99dd402e96d3",
          "763388a5-cc89-4c25-8562-521df679b7e8"
        ],
        "package_ndc": [
          "0173-0873-10",
          "0173-0873-06",
          "66993-189-97"
        ],
        "unii": [
          "7AN603V4JV"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "INCRUSE ELLIPTA",
          "active_ingredients": [
            {
              "name": "UMECLIDINIUM BROMIDE",
              "strength": "EQ 0.0625MG BASE/INH"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "POWDER",
          "route": "INHALATION",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}